Company: IMXI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001683695-25-000030
Chunk: 132

Company: International Money Express, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 132
---
$— Accounts receivable, net— 155,237 — Agent advances, net of allowance— 1,514 — Prepaid wires— 28,366 —    Total assets$239,203 $185,117 $— Accounts payable$— $36,507 $— Wire transfers and money orders payable— 125,042 — Revolving credit facility— 114,000 — Term loan facility— — 77,109    Total liabilities $— $275,549 $77,109 The following tables present the Company's assets measured at fair value on a non-recurring basis at the dates indicated (in thousands):December 31, 2024December 31, 2023Goodwill$55,195 $53,986 Intangible assets, net26,847 18,143 $82,042 $72,129 

NOTE 14 – SHARE-BASED COMPENSATION

International Money Express, Inc. Omnibus Equity Compensation PlansThe International Money Express, Inc. 2020 Omnibus Equity Compensation Plan (the “2020 Plan”) provides for the granting of stock-based incentive awards, including stock options, restricted stock units (“RSUs”), restricted stock awards (“RSAs”) and performance stock units (“PSUs”) to employees, certain service providers and independent directors of the Company. There are approximately 3.7 million shares of the Company’s common stock approved for issuance under the 2020 Plan, which includes 0.4 million shares that were previously subject to awards granted under the International Money Express, Inc. 2018 Omnibus Equity Compensation Plan (the “2018 Plan” and together with the 2020 Plan, the “Plans”). Although awards remain outstanding under the 2018 Plan, which was terminated effective June 

F-24

26, 2020, no additional awards may be granted under the 2018 Plan. As of December 31, 2024, 1.5 million shares remained available for grant of future awards under the 2020 Plan.Stock OptionsThe value of each option grant is estimated on the grant date using the Black-Scholes option pricing model (“BSM”). The option pricing model requires the input of certain assumptions, including the grant date fair value of our common stock, expected volatility, risk-free interest rates, expected term and expected dividend yield. To determine the grant date fair value of